Type 2 diabetes is associated with increased oxidative stress. Free radicals are continuously produced in the body as the result of normal metabolic processes and interaction with environmental stimuli. Under physiological conditions, a wide range of antioxidant defenses protect against adverse effects of free radical production *in vivo*\[[@CIT1]\]. Oxidative stress results from an imbalance between radical production and reduced activity of antioxidant defenses or both these phenomena. Hyperglycemia causes release of tissue damaging reactive oxygen species (ROS) that disturbs balance between radical production and protective antioxidant defense\[[@CIT2]\]. It has been proposed that streptozotocin (STZ) acts as a diabetogenic agent owing to its ability to destroy pancreatic β-cells, possibly by a free radical mechanism\[[@CIT3][@CIT4]\]. The level of lipid peroxidation in cell is controlled by various cellular defense mechanisms consisting of enzymatic and nonenzymatic scavenging systems which are altered in diabetes\[[@CIT5]\]. Moreover, disturbances of antioxidant defense systems in diabetes showed alteration in antioxidant enzyme levels, such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR) along with impaired glutathione (GSH) metabolism\[[@CIT6]\]. Chemical with antioxidant properties and free radical scavengers may help in the regeneration of β-cell and protect pancreatic islets against cytotoxic effect of STZ\[[@CIT7]\]. Antioxidants provide protection in living organisms from damage caused by uncontrolled production of ROS concomitant lipid peroxidation, protein damage and DNA strand breaking. Ethno medical literature contains a large number of plants including,*Calotropis gigantea* R. Br (Asclepiadaceae) that can be used against diseases, like diabetes, atherosclerosis, ischeamic heart disease, disorders induced by free radicals and other reactive oxygen species\[[@CIT8]\]. Hence, the present study was under taken to explore *Calotropis gigantea* R. Br. (Asclepiadaceae) free radical scavenging activity in STZ-induced diabetic rats. In recent years, considerable focus has been given to an intensive search for novel type of antioxidants from numerous plant materials\[[@CIT9]\]. The management of diabetes without any side effects is still a challenge to the medical system. There is an increasing demand by patients for natural antidiabetic products, because insulin and oral hypoglycemic drugs possess undesirable side effects\[[@CIT10]\]. Plants endowed of antidiabetic properties provide useful sources for the development of drugs in the treatment of diabetes mellitus from ancient times; *Swarnabhasma*, an Ayurvedic preparation containing *Calotropis gigantea* R. Br (Asclepiadaceae) is extensively used by Ayurvedic physicians for treatment of disorders such as diabetes mellitus, bronchial asthma, rheumatoid arthritis, and nervous disorders\[[@CIT8]\]. Similar studies on another species *Calotropis procera* reported antioxidant activity against alloxan-induced diabetes in rats\[[@CIT11]\].

The roots of *Calotropis gigantea* have been used in leprosy, eczema, syphilis, elephantiasis, ulceration, antidiarrhoeal, and cough in the Indian system of traditional medicine. The following activities have been reported for *Calotropis gigantea;* prevention of insulin resistance\[[@CIT12]\], hepatoprotective\[[@CIT13]\], antidiarrhoeal\[[@CIT14]\], antipyretic and analgesic\[[@CIT15][@CIT16]\], antiinflammatory\[[@CIT17]\], analgesic activity in Eddy\'s hot plate, and acetic acid-induced writhings\[[@CIT18]\] and wound healing activity\[[@CIT19]\]. The milky juice of *Calotropis gigantea* has been reported as a violent purgative and gastrointestinal irritant and used for inducing abortion\[[@CIT20]\]. The alcohol extract of the flower of *Calotropis gigantea* reported analgesic activity in chemical and thermal models in mice\[[@CIT21]\]. The crude latex extract exhibited strong proteolytic activity, hydrolyses casein, human fibrinogen and crude fibrin clot in a dose-dependent manner\[[@CIT22]\].

Previously isolated classes of constituents include glycosides, proteases, 3\'-methylbutanoates of amyrin, and taraxasterol from *Calotropis gigantea*\[[@CIT23]\], 19-nor- and 18,20-epoxy cardenolides from the leaves of *Calotropis gigantea*\[[@CIT24]\], stigmasterol and ß-sitosterol from methanol extract of root bark of *Calotropis gigantea*\[[@CIT25]\] and a new flavonol trisaccharide\[[@CIT26]\]. Autodigestion of two cystein proteinases, calotropins DI and DII isolated from the latex of *Calotropis gigantea* was studied at 37° (pH 7.5) in the presence of an activated agent; calotropin DI is more susceptible to autodigestion than calotropin DII\[[@CIT27]\]. The three-dimensional structure of sulfhydryl protease calotropin DI from *Calotropis gigantea* closely resembled those found in the sulfhydryl proteases papain and actinidin\[[@CIT28]\].

MATERIALS AND METHODS {#sec1-1}
=====================

Streptozotocin was purchased from Sigma Chemical Co St Louis, USA. Petroleum ether (40-60°), chloroform, ethyl acetate, methanol purchased from Nice Pvt Ltd, India, and other chemical are purchased from Sigma and HiMedia Laboratories Pvt Ltd, Mumbai, India.

Preparation of plant: {#sec2-1}
---------------------

*Calotropis gigantea* leaf and flower were collected from widely growing plants from the region of North Karnataka in the months of Sept-Oct 2005. Plant was authenticated at Department of Botany, B. V. V. Sangh\'s Science College, Bagalkot. An voucher specimen (BSC/BOT/04/09) was deposited in the same Institute.

The plant material was shade-dried and uniformly powdered by passing through the sieve \#44 subjected to hot continuous solvent extraction with petroleum ether (40-60°) to defat the preparation, followed by chloroform, ethyl acetate and methanol for 24 h cycle. The percentage of extract yield leaf and flower 1.32, 1.75, 0.87, 4.45 and 3.45, 2.15, 1.23, 2.10 was calculated in terms of dried weight. The solvent was distilled off, and excess solvent was completely removed by using rotary flash evaporator to get semisolid mass, and dried in lyophilizer (Mini Lyotrap, Serial No. J8199/5, LET Scientific LTD, UK). These extracts were formulated as suspension in distilled water using 5% Tween-80 as a suspending agent\[[@CIT29]\]. When different extracts were tested for hypoglycemic activity on normal rats, the chloroform extract was found to be active, the lowest and safe dose was selected based on the previous studies\[[@CIT12][@CIT14][@CIT18][@CIT20]\], whereas other extracts were found to be inactive. Therefore, the chloroform extract of *Calotropis gigantea* leaf and flower were selected for the present study. Henceforth, chloroform extracts of *Calotropis gigantea* leaf and flower refers to *Calotropis gigantea* extracts.

Wistar rats (150-200 g) were used for this study. They were kept in the animal house for 1 week for proper acclimatization before starting the experiment under controlled condition of illumination (12 h light/dark), and temperature 20-25°. They were housed under ideal laboratory conditions, maintained on standard pellet diet (Lipton rat feed Ltd, Pune), and water *ad libitum* throughout the experimental period. The experimental study was approved by the Institutional Animal\'s Ethics Committee (HSKCP/IAEC/Clear/2004-05).

Induction of diabetes in rats: {#sec2-2}
------------------------------

The STZ was dissolved in citrate buffer (pH 4.5), and rats were made diabetic by injection of a single dose of STZ (55 mg/kg, i.p). They were given 5% of glucose in drinking water for the first 24 h to encounter any initial hypoglycemia. On the 3rd d animals were checked for serum blood glucose levels and those with more than 300 mg/dl were used in the study\[[@CIT30][@CIT31]\]. In our study, a total 54 rats (48 diabetic surviving rats, 6 normal rats) were used. These rats were randomly divided into 9 groups of six rats, after induction of STZ diabetes. Group No.1 (diabetic control) received distilled water in 5% Tween-80. Group No. 2 received glibenclamide (positive control) at an oral dose (10 mg/kg). Group No. 3 (normal) received distilled water in 5% Tween-80. Group No. 4, 5 and 6 received chloroform extract of *Calotropis gigantea* leaf (10, 20 and 50 mg/kg). Group No. 7, 8 and 9 received chloroform extract of *Calotropis gigantea* flower oral dose (10, 20 and 50 mg/kg) for 27 d, respectively.

Preparation of liver homogenate: {#sec2-3}
--------------------------------

The liver was weighed and 10% liver homogenate was prepared with 0.1 M phosphate buffer (pH 7.0) after centrifugation at 1000 rpm for 15 min. The supernatant was used to measure protein, lipid peroxidation (LPO), SOD, and CAT.

Biochemical evaluations: {#sec2-4}
------------------------

The blood serum, SGPT, SGOT, alkaline phosphatase (Alk Phos), cholesterol, and triglyceride were estimated by using commercial diagnostic kit, (Tecodiagnostics, USA) on star-21plus semi-autoanalyser.

Protein content: {#sec2-5}
----------------

The protein content was estimated using a previously reported method\[[@CIT32]\]. Liver homogenate was mixed (1.0 ml) with 2.25 ml of 90% alcohol, and centrifuged at 3000 rpm for 10 min. The supernatant was discarded and the precipitate was dissolved in 1 ml of 0.1N NaoH, to which 1 ml of alkaline mixture was added, set aside for 10 min, 0.5 ml of folin reagent was added and again set aside for 10 min for complete color development. The absorbance was measured at 610 nm. Protein levels were calculated using standard bovine serum solution 200 mg in 100 ml of distilled water.

Lipid peroxidation: {#sec2-6}
-------------------

Lipid peroxidation was estimated by the method\[[@CIT33]\]. Liver homogenate mixed (1.0 ml) with 100 μl of 8.1% sodium dodecyl sulfate (SDS), and 600 μl of 20% acetic acid solution was kept for 2 min at room temperature, then 600 μl of 0.8% solution of TBA, was added, heated at 95° for 60 min in water bath and cooled with ice cold water at 4°. The mixtures of *n*-butanol, and pyridine (15:1, v/v) were added, shaken vigorously and centrifuged at 10.000 rpm for 5 min. The absorbance of the organic layer was measured at 532 nm. Lipid peroxidation was expressed as nmoles of MDA/mg of protein.

Superoxide dismutase: {#sec2-7}
---------------------

The SOD was estimated by the method\[[@CIT34][@CIT35]\], based on the reduction of Nitro blue tetrazolium (NBT) to water insoluble blue formazan. Liver homogenate (0.5 ml) was taken, and 1 ml of 50 mM sodium carbonate, 0.4 ml of 24 μm NBT, and 0.2 ml of 0.1 mM EDTA were added. The reaction was initiated by adding 0.4 ml of 1 mM hydroxylamine hydrochloride. Zero time absorbance was taken at 560 nm followed by 5 min at 25°. The control was simultaneously run without liver homogenate. Units of SOD activity were expressed as the amount of enzyme required to inhibit the reduction of NBT by 50%. The specific activity was expressed in terms of units/mg of protein.

Catalase: {#sec2-8}
---------

Catalase was estimated using a previously reported method\[[@CIT36]\]. The reaction mixture contained 1.0 ml of 0.01 M Phosphate buffer (pH 7.0), 0.1 ml of liver homogenate, and 0.4 ml of 2M H~2~O~2.~ The reaction was stopped by the addition of 2.0 ml of dichromatic-acetic acid reagent. The control was carried out without addition of H~2~O~2,~ and then absorbance was read at 620 nm. CAT activity was expressed as μM of H~2~O~2~ consumed/min/mg protein.

Statistical analysis {#sec2-9}
--------------------

Statistical analysis was performed (GraphPadPrism 5 software, Inc) by using (Unpaired) student *t* test.

RESULTS AND DISCUSSION {#sec1-2}
======================

Liver homogenate of treated, and control rat was used for estimation of LPO, SOD, and CAT. The values observed were expressed as mean±SEM, using unpaired student *t* test as shown in [Table 1](#T0001){ref-type="table"}. The blood serum of treated, and control rats was used to estimate the SGPT, SGOT, Alk Phos, cholesterol, and triglyceride as shown in [Table 2](#T0002){ref-type="table"}. The values obtained clearly reveal that, LPO, SGPT, SGOT, Alk Phos, cholesterol and triglyceride were significantly (P\<0.001) reversed by administration of *Calotropis gigantea* extracts in STZ-induced diabetic rats for 27 d. Consequently, the levels of SOD, and CAT were significantly (P\<0.001) improved after administration of *Calotropis gigantea* extracts in STZ-induced diabetic rats.

###### 

EFFECT OF *CALOTROPIS GIGANTEA* LEAF AND FLOWER EXTRACTS ON LPO, SOD, AND CAT LEVELS IN STZ-INDUCED DIABETIC RATS

  Treatment                                           LPO MDA (nmol/mg protein)                          SOD (Unit/mg protein)                              Catalase (Unit/ mg protein)
  --------------------------------------------------- -------------------------------------------------- -------------------------------------------------- --------------------------------------------------
  Diabetic Control[a](#T000F1){ref-type="table-fn"}   19.73±2.05[\*\*\*](#T000F6){ref-type="table-fn"}   9.81±0.24[\*\*\*](#T000F6){ref-type="table-fn"}    149.4±14.5[\*\*\*](#T000F6){ref-type="table-fn"}
  Gliben[b](#T000F2){ref-type="table-fn"}10 mg/kg     9.13±2.23\*\*                                      14.52±0.70[\*\*\*](#T000F6){ref-type="table-fn"}   314.5±24.1[\*\*\*](#T000F6){ref-type="table-fn"}
  Normal[c](#T000F3){ref-type="table-fn"}             7.48±1.04                                          18.42±1.59                                         321.1±22.5
  CLCH[d](#T000F4){ref-type="table-fn"} 10 mg/kg      11.49±0.84\*\*                                     13.86±1.37\*                                       294.5±42.8\*\*
  CLCH[d](#T000F4){ref-type="table-fn"} 20 mg/kg      13.12±0.88\*                                       15.75±1.44\*\*                                     288.9±34.5\*\*
  CLCH[d](#T000F4){ref-type="table-fn"} 50 mg/kg      11.99±0.80\*\*                                     14.83±0.40[\*\*\*](#T000F6){ref-type="table-fn"}   239.5±0.2\*\*
  CFCH[e](#T000F5){ref-type="table-fn"} 10 mg/kg      12.20±1.18\*\*                                     14.03±0.66[\*\*\*](#T000F6){ref-type="table-fn"}   228.6±19.5\*\*
  CFCH[e](#T000F5){ref-type="table-fn"} 20 mg/kg      12.17±1.09\*\*                                     14.04±0.71[\*\*\*](#T000F6){ref-type="table-fn"}   218.2±22.4\*
  CFCH[e](#T000F5){ref-type="table-fn"} 50 mg/kg      12.96±1.29\*                                       14.82±0.93[\*\*\*](#T000F6){ref-type="table-fn"}   219.0±18.6\*

Diabetic control: 5% Tween-80;

glibenclamide;

normal 5% Tween-80;

*Calotropis gigantea* leaf chloroform;

*Calotropis gigantea* flower chloroform extract. Values are expressed as mean±SEM, n=6 in each group

*P*\<0.001, when (Unpaired t test) compared to diabetic control.

###### 

EFFECT OF *CALOTROPIS GIGANTEA* LEAF AND FLOWER EXTRACTS ON SERUM BIOCHEMICAL PARAMETERS IN STZ-INDUCED DIABETIC RATS

  Treatment                                           SGPT (U/dl)                                           SGOT (U/dl)                                         Alk Phos (U/dl)                                     Cholesterol (U/dl)   Triglycerides (U/dl)
  --------------------------------------------------- ----------------------------------------------------- --------------------------------------------------- --------------------------------------------------- -------------------- ----------------------
  Diabetic control[a](#T000F7){ref-type="table-fn"}   256.80±21.29[\*\*\*](#T000F12){ref-type="table-fn"}   318.0±26.7[\*\*\*](#T000F12){ref-type="table-fn"}   238.5±9.0[\*\*\*](#T000F12){ref-type="table-fn"}    114.5±4.2\*\*        168.0±9.4\*\*
  Gliben[b](#T000F8){ref-type="table-fn"} 10 mg/kg    68.57±6.52[\*\*\*](#T000F12){ref-type="table-fn"}     119.8±6.1[\*\*\*](#T000F12){ref-type="table-fn"}    186.9±10.8\*\*                                      94.71±2.91\*\*       122.2±9.2\*\*
  Normal[c](#T000F9){ref-type="table-fn"}             60.99±2.32                                            64.6±4.67                                           127.4±2.2                                           84.36±3.86           115.1±6.8
  CLCH[d](#T000F10){ref-type="table-fn"} 10 mg/kg     144.80±5.96[\*\*\*](#T000F12){ref-type="table-fn"}    197.6±5.6\*\*                                       189.3±19.6\*                                        97.75±5.04\*         138.6±4.4\*
  CLCH[d](#T000F10){ref-type="table-fn"} 20 mg/kg     151.60±13.03\*\*                                      167.4±7.4[\*\*\*](#T000F12){ref-type="table-fn"}    182.9±19.3\*                                        97.92±2.75\*\*       128.5±3.3\*\*
  CLCH[d](#T000F10){ref-type="table-fn"} 50 mg/kg     129.50±21.91\*\*                                      172.7±14.6[\*\*\*](#T000F12){ref-type="table-fn"}   187.5±6.6\*\*                                       96.66±3.22\*\*       134.3±5.9\*
  CFCH[e](#T000F11){ref-type="table-fn"} 10 mg/kg     65.25±2.91[\*\*\*](#T000F12){ref-type="table-fn"}     158.6±2.8[\*\*\*](#T000F12){ref-type="table-fn"}    176.1±15.1\*\*                                      95.23±3.94\*\*       134.1±3.7\*\*
  CFCH[e](#T000F11){ref-type="table-fn"} 20 mg/kg     66.16±5.26[\*\*\*](#T000F12){ref-type="table-fn"}     150.2±8.5[\*\*\*](#T000F12){ref-type="table-fn"}    102.7±5.1[\*\*\*](#T000F12){ref-type="table-fn"}    88.71±4.34\*\*       133.6±2.9\*\*
  CFCH[e](#T000F11){ref-type="table-fn"} 50 mg/kg     67.61±2.42[\*\*\*](#T000F12){ref-type="table-fn"}     165.5±3.8[\*\*\*](#T000F12){ref-type="table-fn"}    134.9±12.1[\*\*\*](#T000F12){ref-type="table-fn"}   92.50±3.74\*\*       131.8±5.0\*\*

Diabetic control 5% Tween-80;

glibenclamide;

normal 5% Tween-80;

*Caiotropis gigantea* leaf chloroform;

*Caiotropis gigantea* flower chloroform extract. Values are expressed as mean±SEM, n=6 in each group

*P*\<0.001, when (Unpaired t test) compared to diabetic control.

In order to establish a scientific basis for the utility of *Calotropis gigantea* in the treatment of diabetes, it was decided to evaluate free radical scavenging activity in STZ-induced diabetic rats. Earlier reports reveal that STZ-induced diabetic animals may exhibit most of the diabetic complication mediated through oxidative stress\[[@CIT37]\]. Glibenclamide is often used as an insulin stimulant in many studies, and also used as a standard antidiabetic drug in STZ-induced moderate diabetes to compare the antidiabetic properties of a variety of hypoglycemic compounds\[[@CIT37][@CIT38]\]. The findings of our study shows that protection provided by *Calotropis gigantea* extracts could maintain the levels of LPO, SOD, CAT, biomarker enzymes, cholesterol and triglycerides in STZ-induced diabetic rats.

Oxidative stress in diabetes is coupled to a decrease in the antioxidant status, which can increase the deleterious effects of free radicals\[[@CIT39]\]. The SOD and CAT are the two major scavenging enzymes that remove free radicals *in vivo*\[[@CIT40]\]. A decreased activity of these antioxidants can lead to an excess availability of superoxide anion (O~2~^˙־^) and hydrogen peroxide (H~2~O~2~), which in turn generate hydroxyl radicals (^·^OH), resulting in initiation and propagation of LPO. The SOD can catalyze dismutation of (O~2~^˙־^) into H~2~O~2~, which is then deactivated to H~2~O by catalase or SOD works in parallel with selenium-dependent glutathione peroxidase, which plays an important role in the reduction of H~2~O~2~ in the presence of reduced glutathione forming oxidized glutathione, and it protects cell protein and cell membranes against oxidative stress\[[@CIT40][@CIT41]\]. In our study, the SOD and CAT enzymes were significantly (P\<0.001) decreased in STZ-induced diabetic control rats, may be due to inactivation caused by free radicals.

However, administration of *Calotropis gigantea* extracts on LPO levels were significantly reduced by both leaf and flower extract at oral dose (10 mg/kg). The flower extract oral dose (10 mg/kg) has restored SOD levels comparable with positive control, where as leaf extract has shown similar activity at oral dose (50 mg/kg). Where as, there is no significant change on CAT levels neither by leaf nor flower extract even at higher dose.

The SOD and CAT play a prominent role in scavenging free radical and restoring antioxidant activities in the tissue of diabetic animals\[[@CIT42]--[@CIT44]\]. The above observations may clearly suggest that increased levels of SOD and CAT of *Calotropis gigantea* extracts has free radical scavenging activity, which may exert a beneficial effect against pathological alterations caused by reactive oxygen species.

The elevation of biomarker enzymes, such as SGPT, SGOT and Alk Phos was observed in diabetic control rats indicating the hepatic damage\[[@CIT45]\]. The hepatic damage was restored and the transaminases were significantly reduced by flower *Calotropis gigantea* extracts, while leaf extract has less influence, subsequently Alk phos significantly reduced in flower extract at oral dose (20 and 50 mg/kg) than leaf extract at all doses as comparable to positive control. The diabetic complications such as increased gluconeogenesis and ketogenesis may be due to elevated transaminases activity\[[@CIT46]\]. Diabetic control rats show an important lipolytic activity, due to the insulinopenic state which contributes to maintain the abnormally elevated serum cholesterol and triglyceride levels in STZ-induced diabetic rats\[[@CIT47]\]. There is significant decrease in serum cholesterol and triglyceride levels in *Calotropis gigantea* extracts treated rats as evident by reports exhibiting a potent hypocholesterolemic effect. However, the possible underlying mechanism is not elucidated at this stage of the study. The previous studies have reported that administration of *Momordica charantia* lead to decrease in cholesterol levels probably by two mechanisms, one by decreasing absorption of cholesterol from intestine by binding with bile acids within intestine and increasing the extraction of faecales bile acids and the other by biosynthesis of cholesterol especially by decreasing the activity of 3-hydroxyl-3-methly-glutaryl coenzymes A reductase (HMG CoA reductase) an enzyme of cholesterol biosynthesis\[[@CIT47]\]. Same mechanism may be appropriate to explain the observed cholesterol and triglycerides lowering activity by *Calotropis gigantea* extracts.

The qualitative chemical test of the crude extract shows ([Table 3](#T0003){ref-type="table"}) the presence of alkaloids, and flavanol glycoside supporting the earlier studies of *Calotropis gigantea* extracts\[[@CIT12][@CIT14][@CIT23][@CIT26]\]. Flavonoids are a group of naturally occurring compounds widely distributed as secondary metabolite in the plant kingdom\[[@CIT48]\]. One of the flavonoid glycosides prevent oxidant injury and cell death by several mechanism, such as, scavenging oxygen free radicals, protecting antioxidant enzymes, lipid peroxidation\[[@CIT11][@CIT48][@CIT49]\].

###### 

PHYTOCHEMICAL ANALYSIS OF *CALOTROPIS GIGANTEA*

  Chemical components        Leaf   Flowers
  -------------------------- ------ ---------
  Alkaloids                  \+     \+
  Carbohydrate               −      −
  Phytosterols               −      −
  Glycosides                 \+     \+
  Flavonoids                 \+     \+
  Tannins                    \+     \+
  Proteine and amino acids   −      −
  Saponins                   −      −
  Vitamine C                 −      −

In the present study, it is concluded that *Calotropis gigantea* extract has free radical scavenging activity and improved antioxidant effect. The precise mechanism(s) and site(s) of action as well as constituents of *Calotropis gigantea* will be further determined including their toxicological effects.

**Rathod *et al*: Free Radical scavenging activity of *Calotropis gigantea***
